Skip to content

To compare the clinical application of anesthesia management strategy guided by SVV and CVP under the concept of ERAS inlaparoscopic hepatectomy

To compare the clinical application of anesthesia management strategy guided by SVV and CVP under the concept of ERAS inlaparoscopic hepatectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076426
Enrollment
Unknown
Registered
2023-10-08
Start date
2023-10-16
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatectomy

Interventions

CLCVP group:The CVP in the CLCVP group was maintained at 0-5 mmHg by fluid restriction, use of vasoactive drugs, and adjustment of body position until the completion of liver transection. From the com
SVV group:SVV was maintained in the range of 10% to 20% while maintaining CI=2.5L·min-1·m-2 until liver transection was completed. From the completion of liver transection to the end of surgery, SVV w

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Patients of both sexes, aged 18-70 years, undergoing first elective laparoscopic hepatectomy. ?ASA I-II. ?Child-Pugh A/B. ? No accompanying other major surgical procedures, such as intestinal, biliary and pancreatic resection.

Exclusion criteria

Exclusion criteria: ? Patients with disease of heart head blood-vessel ? level and above (hypertension, arrhythmia, cardiomyopathy, myocardial infarction, cerebral infarction). ?Patients with abnormal liver, kidney, lung and endocrine function ?any unstable condition that may endanger the safety and compliance of patients.

Design outcomes

Primary

MeasureTime frame
blood loss;Surgical field classification;

Secondary

MeasureTime frame
fluid infusion;lactic acid;ICU stay time;hemoglobin;creatinine;Blood urea nitrogen;High-sensitivity troponin t;

Countries

China

Contacts

Public ContactSi Yongyu

The Second Affiliated Hospital of Kunming Medical University

15559672131@163.com+86 158 1212 8771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026